Calendar ReShape Lifesciences Inc.

Equities

RSLS

US76090R2004

Market Closed - Nasdaq 01:30:00 28/06/2024 am IST 5-day change 1st Jan Change
0.198 USD 0.00% Intraday chart for ReShape Lifesciences Inc. +5.10% -20.70%

Chart calendar ReShape Lifesciences Inc.

061d.g3dfiZEYwudWtnCjShppMSIGBVxKnj9EkCRs3S94tT4.t0Eb7NVe8Zc80F2bOSMxWkZ3SBUk3G0X3HJcu0sRzU7PHBvoyW-OjBP3Hw~ad5eb67ff62ae54f3df03e5e859f96d4

Upcoming events on ReShape Lifesciences Inc.

12/08/2024 Q2 2024 Earnings Release (Projected)
07/11/2024 Q3 2024 Earnings Release (Projected)
31/03/2025 Q4 2024 Earnings Release (Projected)
20/05/2025 Q1 2025 Earnings Release (Projected)

Past events on ReShape Lifesciences Inc.

16/05/2024 02:00 am Q1 2024 Earnings Call
16/05/2024 01:35 am Q1 2024 Earnings Release
02/04/2024 02:00 am Q4 2023 Earnings Call
02/04/2024 01:35 am Q4 2023 Earnings Release
23/02/2024 10:00 pm Annual General Meeting
09/11/2023 03:30 am Q3 2023 Earnings Call
09/11/2023 02:35 am Q3 2023 Earnings Release
04/10/2023 04:00 am LD Micro Main Conference
08/08/2023 02:30 am Q2 2023 Earnings Call
08/08/2023 01:35 am Q2 2023 Earnings Release
27/06/2023 09:30 pm American Society for Metabolic and Bariatric Surgery Meeting - Poster Number: A223
22/06/2023 08:30 pm OTC Life Science Investor Forum
20/06/2023 11:30 pm Maxim Group Virtual Healthcare Conference
16/05/2023 02:00 am Q1 2023 Earnings Call
16/05/2023 01:35 am Q1 2023 Earnings Release
04/05/2023 08:00 am Keystone Conference - Poster Number: 2004
26/04/2023 02:00 am Q4 2022 Earnings Call
26/04/2023 01:35 am Q4 2022 Earnings Release
29/03/2023 10:30 pm Q2 Virtual Investor Summit
14/12/2022 Annual General Meeting

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023
Net sales
Million USD
Released
Forecast
Spread
0,00


11,3
11,7
-3.43%
13,6
14,2
-4.35%
11,2
11,2
0.2%
8,68
8,90
-2.54%
EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
0,00


-12,5
-11,6
-7.39%
-27,7
-26,1
-6.34%
-46,4
-34,6
-33.89%
-15,4
-15,9
3.33%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-21,8
-16,3
-33.81%
-62,0
-31,6
-96.23%
-46,6
-34,7
-34.28%
-11,3
-12,1
6.24%
Net income
Million USD
Released
Forecast
Spread
-74,2


-21,6
-16,2
-33.52%
-61,9
-31,7
-95.52%
-46,2
-34,8
-32.98%
-11,4
-12,1
5.97%
EPS
USD
Released
Forecast
Spread
-2 147


-156
-117
-33.91%
-250
-145
-72.41%
-109
-85,0
-28.12%
-1,91
-3,84
50.26%
Announcement Date30/04/2010/03/2128/03/2217/04/2301/04/24

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1
Net sales
Million USD
Released
Forecast
Spread
2,44
3,22
-24.28%
2,89
3,41
-15.15%
2,80
3,62
-22.64%
3,11
3,10
0.23%
2,29
2,51
-8.99%
2,25
2,61
-13.64%
2,16
2,40
-10.21%
1,98
2,21
-10.24%
1,94
2,10
-7.6%
EBIT
Million USD
Released
Forecast
Spread
-8,40
-6,08
-38.08%
-9,38
-6,75
-38.89%
-11,9
-6,81
-75.12%
-16,6
-4,92
-238.57%
-5,63
-5,49
-2.66%
-3,98
-5,27
24.58%
-3,88
-4,03
3.65%
-1,90
-2,43
21.89%
-2,21
-2,18
-1.52%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-8,37
-6,15
-36.19%
-9,57
-6,75
-41.72%
-12,2
-6,70
-81.7%
-16,5
-4,60
-258.28%
-2,65
-5,64
53.08%
-3,49
-5,28
33.88%
-3,53
-4,02
12.12%
-1,67
-2,42
31.14%
-2,18
-2,16
-0.74%
Net income
Million USD
Released
Forecast
Spread
-8,22
-6,15
-33.63%
-9,58
-6,75
-41.87%
-11,8
-6,80
-73.61%
-16,6
-4,90
-238.88%
-2,66
-5,64
52.83%
-3,49
-5,28
33.81%
-3,53
-4,02
12.05%
-1,70
-2,42
29.86%
-2,19
-2,16
-1.39%
EPS
USD
Released
Forecast
Spread
-22,0
-17,3
-27.54%
-25,0
-18,0
-38.89%
-26,0
-17,8
-46.48%
-35,9
-10,0
-259%
-1,56
-4,21
62.95%
-1,08
-1,79
39.66%
-1,02
-1,20
15%

-0,18

-0,09
-0,16
43.75%
Announcement Date23/05/2215/08/2214/11/2217/04/2315/05/2307/08/2308/11/2301/04/2415/05/24

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. RSLS Stock
  4. Calendar ReShape Lifesciences Inc.